I think there is a high chance of too and froe discussions going on as they sort things out which may slow the normal timelines.
New ways of doing things can really slow box tickers down in terms of decision making.
Perhaps legal questions and fears are slowing things down too.
- Forums
- ASX - By Stock
- MSB
- Ann: Mesoblast Type A Meeting with FDA
Ann: Mesoblast Type A Meeting with FDA, page-511
-
- There are more pages in this discussion • 64 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.17 |
Change
0.000(0.00%) |
Mkt cap ! $1.358B |
Open | High | Low | Value | Volume |
$1.15 | $1.20 | $1.15 | $1.959M | 1.673M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 5389 | $1.17 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.17 | 45420 | 12 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
20 | 18901 | 1.165 |
18 | 110979 | 1.160 |
17 | 180071 | 1.155 |
21 | 604153 | 1.150 |
7 | 63425 | 1.145 |
Price($) | Vol. | No. |
---|---|---|
1.170 | 31596 | 16 |
1.175 | 19663 | 9 |
1.180 | 106052 | 12 |
1.185 | 98273 | 12 |
1.190 | 166374 | 12 |
Last trade - 12.18pm 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, CEO / Non-Exec Director
James Graham / Dr Alan Dunton
CEO / Non-Exec Director
SPONSORED BY The Market Online